Guidance for DPIA Practices: A New Whitepaper for EU-Funded Projects
As health research becomes increasingly data-driven, ensuring robust data protection and ethical handling of sensitive information is more important than ever. When dealing with technologies like Federated Learning and cross-border data sharing, the risks to privacy grow, and so does the need for clear, actionable guidance. To address this, ONCOVALUE is proud to have contributed […]
Tracking Cancer Over Time: ONCOVALUE’s Unique Annotated Dataset
ONCOVALUE has developed a unique annotated dataset to train an AI-based imaging tool designed to support the assessment of metastatic breast cancer. With Siemens Healthineers leading its development, the tool ultimately aims to help evaluate which therapies are effective by providing objective, image-based information on disease progression. Using longitudinal medical imaging data (i.e. imaging data […]
ONCOVALUE Joins the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) Cluster
We are excited to announce that ONCOVALUE has officially joined the Cancer Survivorship – Artificial Intelligence Working Group (CS-AIW) cluster, a European initiative focused on advancing cancer research through the application of artificial intelligence (AI). The CS-AIW cluster brings together European projects dedicated to improving cancer outcomes. Through collaboration and shared expertise, this cluster aims […]
ONCOVALUE opens call for expressions of interest to participate in project’s validation activities
ONCOVALUE is a consortium of cancer institutes and commercial businesses that are working together to implement value-based oncology care by enabling and guiding cancer hospitals to collect, harmonize and analyse high-quality Real-World Data (RWD) in real-time, supporting cost-effectiveness evaluation of novel cancer therapies. The project is funded by the European Union under the call ‘HORIZON-HLTH […]
Advancing AI in cancer research: Insights from ONCOVALUE, EUCanImage, and RadioVal
An Exchange of Lessons Learned session brought together representatives from three European-funded projects: ONCOVALUE, EUCanImage, and RadioVal, to share experiences and challenges in developing artificial intelligence (AI) for cancer research.Organized by CiaoTech, ttopstart, and the University of Barcelona, the session served as a platform to reflect on challenges such as data accessibility, quality, and standardization, […]
Event X Life Science
Our partner CiaoTech/PNO joined the Event X Life Science, the premier Italian matchmaking and innovation event in the field of Life Sciences. This dynamic event was held on 8th and 9th, October 2024 in Firenze. This event serves as a vibrant platform where industry leaders, researchers, investors, public institutions, and media representatives convene to explore cutting-edge […]
ONCOVALUE installs ethics advisory board Independent body will monitor and advise on ethics and legal aspects of the research
Utrecht, 08-07-2024 – ONCOVALUE, a consortium of cancer hospitals and commercial companies that are working together to implement value-based oncology care, has installed its ethics advisory board. The board consists of respected leaders in their respective fields of expertise from a variety of European countries. The ONCOVALUE research focuses on enabling and guiding cancer hospitals […]
First milestones reached in project aiming to enable value-based oncology care in Europe
ONCOVALUE consortium sees solid results from the first year with promising outlook for years to come Utrecht, 20-2-2024 – ONCOVALUE, a consortium of cancer hospitals and commercial companies that are working together to implement value-based oncology care, completed its first year of research. The ONCOVALUE research focusses on enabling and guiding cancer hospitals to collect, […]
Working towards automated evaluation of the effectiveness of cancer treatment
In the near future, information about the effectiveness of medical treatment recorded at patient visits will turn into valuable data, which can be directly used to evaluate the effectiveness of treatments. ONCOVALUE is an excellent example of international cooperation where everything happens much faster as strengths and skills are shared and learned from each other. […]
Consortium Meeting November 2023
On November 6-7 2023 ONCOVALUE held its second Consortium Meeting in Milan. Since the start of the ONCOVALUE project in December 2022 this was the second time all the members of the consortium came together to share insights and knowledge. Over the course of two days, several of the partners delivered engaging presentations to showcase […]
